Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1986 May;79(5):282–288. doi: 10.1177/014107688607900508

Gilles de la Tourette syndrome: a review.

M Lawden
PMCID: PMC1290313  PMID: 3522904

Full text

PDF
282

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abuzzahab F. E., Sr, Anderson F. O. Gilles de la Tourette's syndrome; international registry. Minn Med. 1973 Jun;56(6):492–496. [PubMed] [Google Scholar]
  2. Bergen D., Tanner C. M., Wilson R. The electroencephalogram in Tourette syndrome. Ann Neurol. 1982 Apr;11(4):382–385. doi: 10.1002/ana.410110411. [DOI] [PubMed] [Google Scholar]
  3. Bleeker H. E. Gilles de la Tourette's syndrome with direct evidence of organicity. Psychiatr Clin (Basel) 1978;11(3):147–154. doi: 10.1159/000283745. [DOI] [PubMed] [Google Scholar]
  4. Borison R. L., Ang L., Chang S., Dysken M., Comaty J. E., Davis J. M. New pharmacological approaches in the treatment of Tourette syndrome. Adv Neurol. 1982;35:377–382. [PubMed] [Google Scholar]
  5. Bremness A. B., Sverd J. Methylphenidate-induced Tourette syndrome: case report. Am J Psychiatry. 1979 Oct;136(10):1334–1335. doi: 10.1176/ajp.136.10.1334. [DOI] [PubMed] [Google Scholar]
  6. Bruhn P., Olesen J., Melgaard B. Controlled trial of EMG feedback in muscle contraction headache. Ann Neurol. 1979 Jul;6(1):34–36. doi: 10.1002/ana.410060108. [DOI] [PubMed] [Google Scholar]
  7. Bruun R. D. Gilles de la Tourette's syndrome. An overview of clinical experience. J Am Acad Child Psychiatry. 1984 Mar;23(2):126–133. doi: 10.1097/00004583-198403000-00002. [DOI] [PubMed] [Google Scholar]
  8. Caparulo B. K., Cohen D. J., Rothman S. L., Young J. G., Katz J. D., Shaywitz S. E., Shaywitz B. A. Computed tomographic brain scanning in children with developmental neuropsychiatric disorders. J Am Acad Child Psychiatry. 1981 Spring;20(2):338–357. doi: 10.1016/s0002-7138(09)60993-6. [DOI] [PubMed] [Google Scholar]
  9. Chase T. N., Foster N. L., Fedio P., Brooks R., Mansi L., Kessler R., Di Chiro G. Gilles de la tourette syndrome: studies with the fluorine-18-labeled fluorodeoxyglucose positron emission tomographic method. Ann Neurol. 1984;15 (Suppl):S175–S175. doi: 10.1002/ana.410150733. [DOI] [PubMed] [Google Scholar]
  10. Cohen D. J., Detlor J., Young J. G., Shaywitz B. A. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry. 1980 Dec;37(12):1350–1357. doi: 10.1001/archpsyc.1980.01780250036004. [DOI] [PubMed] [Google Scholar]
  11. Cohen D. J., Shaywitz B. A., Caparulo B., Young J. G., Bowers M. B., Jr Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry. 1978 Feb;35(2):245–250. doi: 10.1001/archpsyc.1978.01770260123015. [DOI] [PubMed] [Google Scholar]
  12. Cohen D. J., Shaywitz B. A., Young J. G., Carbonari C. M., Nathanson J. A., Lieberman D., Bowers M. B., Jr, Maas J. W. Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry. 1979 Spring;18(2):320–341. doi: 10.1016/s0002-7138(09)61046-3. [DOI] [PubMed] [Google Scholar]
  13. Cohen D. J., Young J. G., Nathanson J. A., Shaywitz B. A. Clonidine in Tourette's syndrome. Lancet. 1979 Sep 15;2(8142):551–553. doi: 10.1016/s0140-6736(79)91614-3. [DOI] [PubMed] [Google Scholar]
  14. Comings D. E., Comings B. G., Devor E. J., Cloninger C. R. Detection of major gene for Gilles de la Tourette syndrome. Am J Hum Genet. 1984 May;36(3):586–600. [PMC free article] [PubMed] [Google Scholar]
  15. Comings D. E., Comings B. G. Tourette's syndrome and attention deficit disorder with hyperactivity: are they genetically related? J Am Acad Child Psychiatry. 1984 Mar;23(2):138–146. doi: 10.1097/00004583-198403000-00004. [DOI] [PubMed] [Google Scholar]
  16. Deecke L., Kornhuber H. H. An electrical sign of participation of the mesial 'supplementary' motor cortex in human voluntary finger movement. Brain Res. 1978 Dec 29;159(2):473–476. doi: 10.1016/0006-8993(78)90561-9. [DOI] [PubMed] [Google Scholar]
  17. Devor E. J. Complex segregation analysis of Gilles de la Tourette syndrome: further evidence for a major locus mode of transmission. Am J Hum Genet. 1984 May;36(3):704–709. [PMC free article] [PubMed] [Google Scholar]
  18. Dominguez R. A. Tardive dyskinesia following low doses of piperacetazine. Am J Psychiatry. 1980 Dec;137(12):1617–1617. doi: 10.1176/ajp.137.12.1617. [DOI] [PubMed] [Google Scholar]
  19. EHRINGER H., HORNYKIEWICZ O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin Wochenschr. 1960 Dec 15;38:1236–1239. doi: 10.1007/BF01485901. [DOI] [PubMed] [Google Scholar]
  20. Fahn S. A case of post-traumatic tic syndrome. Adv Neurol. 1982;35:349–350. [PubMed] [Google Scholar]
  21. Feild J. R., Corbon K. B., Goldstein N. P., Klass D. W. Gilles de la Tourette's syndrome. Neurology. 1966 May;16(5):453–462. doi: 10.1212/wnl.16.5.453. [DOI] [PubMed] [Google Scholar]
  22. Feinberg M., Carroll B. J. Effects of dopamine agonists and antagonists in Tourette's disease. Arch Gen Psychiatry. 1979 Aug;36(9):979–985. doi: 10.1001/archpsyc.1979.01780090065007. [DOI] [PubMed] [Google Scholar]
  23. Fras I., Karlavage J. The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children. Am J Psychiatry. 1977 Feb;134(2):195–197. doi: 10.1176/ajp.134.2.195. [DOI] [PubMed] [Google Scholar]
  24. Goetz C. G., Tanner C. M., Klawans H. L. Fluphenazine and multifocal tic disorders. Arch Neurol. 1984 Mar;41(3):271–272. doi: 10.1001/archneur.1984.04050150049015. [DOI] [PubMed] [Google Scholar]
  25. Golden G. S. Gilles de la Tourette's syndrome following methylphenidate administration. Dev Med Child Neurol. 1974 Feb;16(1):76–78. doi: 10.1111/j.1469-8749.1974.tb02715.x. [DOI] [PubMed] [Google Scholar]
  26. Golden G. S. The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol. 1977 Jul;2(1):69–70. doi: 10.1002/ana.410020113. [DOI] [PubMed] [Google Scholar]
  27. Golden G. S. Tics and Tourette's: a continuum of symptoms? Ann Neurol. 1978 Aug;4(2):145–148. doi: 10.1002/ana.410040208. [DOI] [PubMed] [Google Scholar]
  28. Gonce M., Barbeau A. Seven cases of Gilles de la tourette's syndrome: partial relief with clonazepam: a pilot study. Can J Neurol Sci. 1977 Nov;4(4):279–283. doi: 10.1017/s0317167100025129. [DOI] [PubMed] [Google Scholar]
  29. Guggenheim M. A. Familial Tourette syndrome. Ann Neurol. 1979 Jan;5(1):104–104. doi: 10.1002/ana.410050119. [DOI] [PubMed] [Google Scholar]
  30. Jagger J., Prusoff B. A., Cohen D. J., Kidd K. K., Carbonari C. M., John K. The epidemiology of Tourette's syndrome: a pilot study. Schizophr Bull. 1982;8(2):267–278. doi: 10.1093/schbul/8.2.267. [DOI] [PubMed] [Google Scholar]
  31. Jenkins R. L., Ashby H. B. Gilles de la Tourette's syndrome in identical twins. Arch Neurol. 1983 Apr;40(4):249–251. doi: 10.1001/archneur.1983.04050040079016. [DOI] [PubMed] [Google Scholar]
  32. KORNHUBER H. H., DEECKE L. HIRNPOTENTIALAENDERUNGEN BEI WILLKUERBEWEGUNGEN UND PASSIVEN BEWEGUNGEN DES MENSCHEN: BEREITSCHAFTSPOTENTIAL UND REAFFERENTE POTENTIALE. Pflugers Arch Gesamte Physiol Menschen Tiere. 1965 May 10;284:1–17. [PubMed] [Google Scholar]
  33. Klawans H. L., Falk D. K., Nausieda P. A., Weiner W. J. Gilles de la Tourette syndrome after long-term chlorpromazine therapy. Neurology. 1978 Oct;28(10):1064–1066. doi: 10.1212/wnl.28.10.1064. [DOI] [PubMed] [Google Scholar]
  34. Klempel K. Gilles de la Tourette's symptoms induced by L-dopa. S Afr Med J. 1974 Jul 6;48(32):1379–1380. [PubMed] [Google Scholar]
  35. Krumholz A., Singer H. S., Niedermeyer E., Burnite R., Harris K. Electrophysiological studies in Tourette's syndrome. Ann Neurol. 1983 Dec;14(6):638–641. doi: 10.1002/ana.410140606. [DOI] [PubMed] [Google Scholar]
  36. Lees A. J., Robertson M., Trimble M. R., Murray N. M. A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J Neurol Neurosurg Psychiatry. 1984 Jan;47(1):1–8. doi: 10.1136/jnnp.47.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Messiha F. S., Knopp W. A study of endogenous dopamine metabolism in Gilles de la Tourette's disease. Dis Nerv Syst. 1976 Aug;37(8):470–473. [PubMed] [Google Scholar]
  38. Moldofsky H., Tullis C., Lamon R. Multiple tic syndrome (Giles de la Tourette's syndrome). J Nerv Ment Dis. 1974 Oct;159(4):282–292. doi: 10.1097/00005053-197410000-00007. [DOI] [PubMed] [Google Scholar]
  39. Murray T. J. Dr Samuel Johnson's movement disorder. Br Med J. 1979 Jun 16;1(6178):1610–1614. doi: 10.1136/bmj.1.6178.1610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nee L. E., Caine E. D., Polinsky R. J., Eldridge R., Ebert M. H. Gilles de la Tourette syndrome: clinical and family study of 50 cases. Ann Neurol. 1980 Jan;7(1):41–49. doi: 10.1002/ana.410070109. [DOI] [PubMed] [Google Scholar]
  41. Nomura Y., Segawa M. Gilles de la Tourette syndrome in Oriental children. Brain Dev. 1979;1(2):103–111. doi: 10.1016/s0387-7604(79)80018-2. [DOI] [PubMed] [Google Scholar]
  42. Nuwer M. R. Coprolalia as an organic symptom. Adv Neurol. 1982;35:363–368. [PubMed] [Google Scholar]
  43. Obeso J. A., Rothwell J. C., Marsden C. D. Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential. J Neurol Neurosurg Psychiatry. 1981 Aug;44(8):735–738. doi: 10.1136/jnnp.44.8.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Obeso J. A., Rothwell J. C., Marsden C. D. The neurophysiology of Tourette syndrome. Adv Neurol. 1982;35:105–114. [PubMed] [Google Scholar]
  45. Pollack M. A., Cohen N. L., Friedhoff A. J. Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy. Arch Neurol. 1977 Oct;34(10):630–632. doi: 10.1001/archneur.1977.00500220064011. [DOI] [PubMed] [Google Scholar]
  46. Pulst S. M., Walshe T. M., Romero J. A. Carbon monoxide poisoning with features of Gilles de la Tourette's syndrome. Arch Neurol. 1983 Jul;40(7):443–444. doi: 10.1001/archneur.1983.04050070073019. [DOI] [PubMed] [Google Scholar]
  47. Richardson E. P., Jr Neuropathological studies of Tourette syndrome. Adv Neurol. 1982;35:83–87. [PubMed] [Google Scholar]
  48. Rose M. S., Moldofsky H. Comparison of pimozide with haloperidol in Gilles de la Tourette syndrome. Lancet. 1977 Jan 8;1(8002):103–103. doi: 10.1016/s0140-6736(77)91126-6. [DOI] [PubMed] [Google Scholar]
  49. SEIGNOT J. N. [A case of tic of Gilles de la Tourette cured by R 1625]. Ann Med Psychol (Paris) 1961 Mar;119(1):578–579. [PubMed] [Google Scholar]
  50. Sacks O. W. Acquired Tourettism in adult life. Adv Neurol. 1982;35:89–92. [PubMed] [Google Scholar]
  51. Sethy V. H., Van Woert M. H. Regulation of striatal acetylcholine concentration by dopamine receptors. Nature. 1974 Oct 11;251(5475):529–530. doi: 10.1038/251529a0. [DOI] [PubMed] [Google Scholar]
  52. Shapiro A. K., Shapiro E. Controlled study of pimozide vs. placebo in Tourette's syndrome. J Am Acad Child Psychiatry. 1984 Mar;23(2):161–173. doi: 10.1097/00004583-198403000-00007. [DOI] [PubMed] [Google Scholar]
  53. Shapiro A. K., Shapiro E. Tourette syndrome: history and present status. Adv Neurol. 1982;35:17–23. [PubMed] [Google Scholar]
  54. Shapiro A. K., Shapiro E. Tourette syndrome: history and present status. Adv Neurol. 1982;35:17–23. [PubMed] [Google Scholar]
  55. Shapiro A. K., Shapiro E., Wayne H. L., Clarkin J., Bruun R. D. Tourette's syndrome: summary of data on 34 patients. Psychosom Med. 1973 Sep-Oct;35(5):419–435. doi: 10.1097/00006842-197309000-00006. [DOI] [PubMed] [Google Scholar]
  56. Shapiro A. K., Shapiro E., Wayne H. Treatment of Tourette's syndrome with haloperidol, review of 34 cases. Arch Gen Psychiatry. 1973 Jan;28(1):92–97. doi: 10.1001/archpsyc.1973.01750310070010. [DOI] [PubMed] [Google Scholar]
  57. Singer H. S., Tune L. E., Butler I. J., Zaczek R., Coyle J. T. Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome. Adv Neurol. 1982;35:177–183. [PubMed] [Google Scholar]
  58. Sleator E. K. Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome. Clin Pediatr (Phila) 1980 Jul;19(7):453–454. doi: 10.1177/000992288001900704. [DOI] [PubMed] [Google Scholar]
  59. Stahl S. M., Berger P. A. Cholinergic and dopaminergic mechanisms in Tourette syndrome. Adv Neurol. 1982;35:141–150. [PubMed] [Google Scholar]
  60. Stahl S. M., Berger P. A. Physostigmine in Gilles de la Tourette's syndrome. N Engl J Med. 1980 Jan 31;302(5):298–298. doi: 10.1056/nejm198001313020517. [DOI] [PubMed] [Google Scholar]
  61. Stahl S. M., Berger P. A. Physostigmine in Tourette syndrome: evidence for cholinergic underactivity. Am J Psychiatry. 1981 Feb;138(2):240–242. doi: 10.1176/ajp.138.2.240. [DOI] [PubMed] [Google Scholar]
  62. Stevens H. Gilles de la Tourette and his syndrome by serendipity. Am J Psychiatry. 1971 Oct;128(4):489–492. doi: 10.1176/ajp.128.4.489. [DOI] [PubMed] [Google Scholar]
  63. Svensson T. H., Bunney B. S., Aghajanian G. K. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res. 1975 Jul 11;92(2):291–306. doi: 10.1016/0006-8993(75)90276-0. [DOI] [PubMed] [Google Scholar]
  64. Sweet R. D., Solomon G. E., Wayne H., Shapiro E., Shapiro A. K. Neurological features of Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):1–9. doi: 10.1136/jnnp.36.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Volkmar F. R., Leckman J. F., Detlor J., Harcherik D. F., Prichard J. W., Shaywitz B. A., Cohen D. J. EEG abnormalities in Tourette's syndrome. J Am Acad Child Psychiatry. 1984 May;23(3):352–353. doi: 10.1016/s0002-7138(09)60516-1. [DOI] [PubMed] [Google Scholar]
  66. Wassman E. R., Eldridge R., Abuzzahab S., Sr, Nee L. Gilles de la Tourette syndrome: clinical and genetic studies in a midwestern city. Neurology. 1978 Mar;28(3):304–307. doi: 10.1212/wnl.28.3.304. [DOI] [PubMed] [Google Scholar]
  67. van Woert M. H., Rosenbaum D., Enna S. J. Overview of pharmacological approaches to therapy for Tourette syndrome. Adv Neurol. 1982;35:369–375. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES